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Abstract 
 
Since its inception, cardiac pacing has made a significant advancement in cardiology. As new 
therapies and devices emerge, the number of implantations is steadily increasing which requires 
up-to-date clinical guidelines for management. Although advanced, these mechanical devices 
often require maintenance and revisions to achieve optimal performance. One of the most 
common deteriorations is lead failure.  
 
In the case of lead failure requiring revision, new lead implant, or upgrading to a more advanced 
pacing system, venous stenosis resulting in partial or complete obstruction of the vessel can pose 
a real problem. This case series report introduces the technique of percutaneous transluminal 
balloon venoplasty in the setting of venous stenosis as an alternative to more invasive procedures 
such as lead extraction for lead revision or device upgrade. 
 
Keywords 
 
Percutaneous transluminal balloon venoplasty; pacemaker lead deterioration; lead revision 
 
Introduction 
 
Artificial cardiac pacemakers have come a long way since Albert S. Hyman’s external cardiac 
pacemaker system in 1932. Major advancements in cardiac pacing occurred in the 1950s, 
including the first complete implantation of an epicardial pacing system and a transvenous 
temporary pacing lead.1  
 
With the invention of transvenous implantable cardioverter-defibrillator (ICD) leads in the early 
1980s, management of arrhythmias and heart failure improved significantly.2-4 Over past several 
decades, novel therapies have developed and, as a result, the number of pacemaker implantations 
have steadily increased. Furthermore, with the improvement in technology, patients with older 
systems have required upgrades to ICDs and/or dual and biventricular pacing systems.5 In these 
procedures, access to the subclavian veins is paramount to the success of the operation. 
However, as with any procedure requiring central venous access and insertion of leads, venous 
stenosis can occur. 
 
Patients with venous stenosis rarely report significant clinical symptoms due to the development 
of adequate venous collateral circulation.6 Young, active patients are more likely to be 
symptomatic. Unfortunately, if a patient requires implantation of additional leads, partial or 
complete venous stenosis can impede and complicate the procedure.7 
 
There are numerous solutions to this dilemma. These solutions include: extracting one lead to 
gain access; implant the new lead in the opposite side then tunnel it to the same pocket; or 
implant epicardial lead surgically.7 As an alternative to these invasive and risky procedures for 
new lead implant, we describe a less invasive technique in the setting of venous stenosis: 
percutaneous transluminal balloon venoplasty. 
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Case Series 
 
Case I 
 
A 74-year-old male with a history of recurrent syncope related to hypotension caused by frequent 
premature ventricular contractions (PVCs) and bradycardia secondary to first-degree heart block 
and bundle branch block underwent a dual chamber pacemaker implantation. The patient was on 
hemodialysis and met Class I indication for a pacemaker implant. 
 
The venography showed a complete obstruction of the patient’s left subclavian and innominate 
veins (Figure 1A) which challenged the left-sided access to the heart, rendering right-sided 
access the alternative option for the implant procedure. However, the patient had a failed 
arteriovenous fistula (AVF) on the left arm for hemodialysis, which resulted in a second AVF 
creation on the right arm, and it was not advised to implant on the same side of the fistula. The 
interventional cardiologist was consulted to assess the possibility of patency restoration of the 
left veins. Angioplasty was successfully performed using an Evercross 9/150mm balloon 
(Figures 1B and 1C). The transvenous pacemaker implantation was subsequently performed 
through the left subclavian vein, and the leads were placed without any difficulties. This resulted 
in a successful pacemaker implantation while reserving the right AVF function. 
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Figure 1A. Pre-venoplasty 
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Figure 1B. Venoplasty 
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Figure 1C. Venoplasty 
 
 
 
Case II 
 
A 67-year-old female with a single chamber ICD and a history of severe ischemic 
cardiomyopathy, atrial fibrillation, and LBBB with wide QRS and ventricular tachycardia 
underwent CRT-D upgrade which required the addition of an LV lead. The pre-existing 
generator previously implanted via left infraclavicular vein was explanted to implant the newer 
generator with more than one lead port. 
 
The venous access was gained through the left subclavian vein. However, attempts to advance 
the wire beyond the innominate vein encountered difficulties despite the use of multiple wires, 
19
Marshall Journal of Medicine, Vol. 5 [2019], Iss. 1, Art. 4
https://mds.marshall.edu/mjm/vol5/iss1/4
DOI: 10.33470/2379-9536.1188
 including the Wholey wire and the Glidewire. A venogram showed a total obstruction in distal 
innominate vein (Figure 2A). 
 
 
 
 
Figure 2A. Pre-venoplasty 
 
 
An interventional radiologist was consulted for a balloon venoplasty, which resulted in a 
successful dilation of the vein (Figures 2B and 2C). Subsequently, the wire was advanced 
through the dilated left vein and the left ventricular lead placed. Then, the right atrial lead was 
placed on the right side of the heart which completed the upgrade procedure. 
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Figure 2B. Venoplasty 
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Figure 2C. Post-venoplasty 
 
 
Case III 
 
A 77-year-old male with severe cardiomyopathy and NYHA Class 3 CHF symptoms presented 
with a dual chamber ICD that reached elective replacement interval. The patient was scheduled 
to receive CRT-D upgrade. The LV lead placement was indicated due to cardiomyopathy, 
prominent PR prolongation more than 300 ms, and V-pacing at 100% with QRS of almost 200 
ms. 
 
The attempt to upgrade was unsuccessful because the left subclavian vein was subtotally 
occluded (Figure 3A). An interventional cardiologist was consulted to dilate the occluded vessel. 
The right femoral vein from below and the left accessory vein from above were accessed without 
any difficulties, and an angiogram was obtained through the innominate vein and superior vena 
cava which showed a clear occlusion of the left innominate vein. 
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Figure 3A. Pre-venoplasty 
 
 
The wire was advanced until it reached the right atrium through a slender sheath that was 
introduced via the left accessory vein access. A 5.0 balloon was initially used followed by a 9/80 
Mustang balloon which was inflated for a total of 8 atmospheres for 2 minutes (Figure 3B). 
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Figure 3B. Venoplasty 
 
 
A post-dilation angiogram showed a complete resolution of stenosis throughout the course of the 
innominate vein with 10% residual and no immediate complications (Figure 3C). After the 
procedure, EP cardiology proceeded with the CRT-D generator change and LV lead implant on 
the same side of pre-existing generator. 
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Figure 3C. Post-venoplasty 
 
 
Discussion 
 
Transvenous introduction of the leads through the subclavian vein is the most commonly used 
technique for pacemaker or ICD device placement. The leads are well known to be susceptible to 
multiple different problems: fracture of the leads from deterioration, insulation defects, 
connector issues, and infections.1  
 
In addition, the leads can cause deep venous thrombosis or irritate the vessel wall at the site of 
lead intersection which can result in development of venous stenosis.1,8 Venous stenosis can be a 
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 challenge for the operator if the patient requires the implantation of new leads. Therefore, 
patency of the accessible veins is a critical factor for procedural success.5 
 
In association with permanent transvenous pacemaker electrodes, the incidence of partial venous 
obstruction varies from 31% to 50% with up to one-third of patients having total venous 
occlusions9,10. In a recent prospective study, about 26% of patients with pacemakers or ICD 
systems were found to have a total occlusion of the subclavian or innominate vein, and up to 
25% of them have significant venous stenosis (>50%) with a mean time of 6.2 years since 
implantation.5 
 
Venous stenosis, a well-recognized complication of pacemaker or ICD lead placement, can cause 
perplexing situations during the lead revision or replacement. Without doubt, total venous 
occlusion proves to be more challenging and leaves the operator with limited choices. In 
situations of total venous occlusion, there are two main options: an extraction of a functional lead 
in order to get access; or an implantation of the lead on the opposite side and then tunneling it to 
the pocket. Using the opposite side may not be an option in the presence of an AV fistula. It may 
be possible to get access into the vein medial to the obstruction. Epicardial implantation by a 
surgeon could be the last resort if a ventricular lead is needed.7  
 
A more recent technique is to use a leadless device such as Micra for pacing the right ventricle. 
To bypass the downfalls of these previously described solutions to transvenous lead revision or 
device upgrade with venous stenosis, a new option that is gaining interest is the successful 
dilatation of venous stenosis. This technique avoids more invasive options. Percutaneous 
transluminal balloon venoplasty can be performed safely, provided the procedure is performed 
by personnel with adequate training and the necessary equipment is readily available. Lead 
implant can take place the following day while the patient remains anticoagulated with IV 
heparin to prevent closure of the vein. 
 
It has been established that in symptomatic cases of venous stenosis resulting in superior vena 
cava syndrome (SVC syndrome), an option to relieve the symptoms is to place a stent in the area 
of stenosis.11,12 In the cases described, these lesions are found incidentally in asymptomatic 
patients. Venoplasty is sufficient in dilating the vein to allow for pacemaker lead revision.13 
While stenting would remain a potential option for venous stenosis found when attempting 
pacemaker lead revision, it would require the patients to also take antiplatelet medication 
following the placing of the stent, which could lead to further bleeding complications. 
 
Although there are some potential risks associated with percutaneous transluminal balloon 
venoplasty, its benefits may outweigh the risks. This technique can avoid proceeding with more 
invasive options such as surgical access or using other veins with potential future stenosis. Since 
veins have thinner walls and are less elastic compared to arteries, there is a possibility of 
rupturing the vein during the balloon venoplasty procedure. This could result in potential 
intrathoracic hematoma which may require further invasive procedures for it to resolve. While 
wiring a distal occlusion does not pose the risk of cardiac tamponade, the complications of 
pacemaker lead insertion are still present. The incidence of complications with percutaneous 
transluminal balloon venoplasty remains yet to be defined. Moreover, the routine use of 
preoperative venography prior to pacemaker lead revision is recommended to detect significant 
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 occlusive venous disease and to aid in determining the optimal route of electrode placement and 
the type of operating room as a hybrid room would be preferred when extraction is needed. 
Conclusion 
 
The adjunct use of antiplatelet agents and anticoagulants has not been adequately studied after 
venous stenting. Based upon the underlying pathophysiology, extrapolation of results from 
arterial interventions, and clinical experience, there seems to be a role for these agents. 
Antiplatelet agents would be most appropriate for patients with primary vein lesions while 
anticoagulants would have a greater role in post-thrombotic disease.14 In a recent study, the 
current consensus is to utilize anticoagulant therapy following venous stenting while it lacks 
evidence with respect to the role of antiplatelet agents.15 Given the lack of evidence supporting 
the use of both antiplatelet agents and anticoagulants, a careful assessment of the risks and 
benefits in the individual patients would be warranted.14 
 
Transluminal balloon venoplasty technique is an option that can help avoid more invasive 
alternatives. It also spares other veins as access, hence preventing the potential for future 
stenosis. This option should be considered before extraction of a functional lead or attempting to 
get access on the contralateral side. Although the incidence of complications of venoplasty are 
still yet to be defined, its benefits may outweigh the risks when compared to alternative 
techniques for pacemaker lead revision in the setting of venous stenosis. 
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 Abbreviations 
 
AF – Atrial fibrillation 
CHF – Congestive Heart Failure 
CRT – Cardiac Resynchronization Therapy 
CS – Coronary Sinus 
EF – Ejection Fraction 
EP – Electrophysiology 
ICD – Implantable Cardioverter-Defibrillator 
LBBB – Left Branch Bundle Block 
LV – Left Ventricle/Ventricular 
MRI – Magnetic Resonance Imaging 
NYHA – New York Heart Association 
PVC – Premature Ventricular Contraction 
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